A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).
Kristian ReichI ZschockeH BachelezE M G J de JongPaolo GisondiLluis L PuigR B WarrenC OrtlandU Mrowietznull nullPublished in: The British journal of dermatology (2017)
Patients randomized to the TTOP intervention had a better clinical response than patients receiving standard of care. Improved communication between the healthcare provider and patient might be an important element in increasing adherence to topical therapy in psoriasis.
Keyphrases
- healthcare
- end stage renal disease
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- open label
- primary care
- prognostic factors
- peritoneal dialysis
- type diabetes
- study protocol
- case report
- mesenchymal stem cells
- metabolic syndrome
- insulin resistance
- phase iii
- social media
- pain management
- atopic dermatitis
- hyaluronic acid